| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/16/2013 | CN102871966A Nano drug carrier particles for improving bioavailability of rapamycin and preparation method thereof |
| 01/16/2013 | CN102871964A Stable and efficient propofol middle/long-chain fat emulsion injection and preparation method thereof |
| 01/16/2013 | CN102871961A Injection containing tirofiban |
| 01/16/2013 | CN102871960A Lentinan injection and preparation method thereof |
| 01/16/2013 | CN102871958A Medicinal composition containing monoammonium glycyrrhizinate compound and preparation method thereof |
| 01/16/2013 | CN102871956A Propranolol hydrochloride gel for treating infant superficial hemangioma |
| 01/16/2013 | CN102871955A Ointment medicament composition containing mupirocin |
| 01/16/2013 | CN102871953A Super-absorbent adsorption suppository |
| 01/16/2013 | CN102871951A Hyaluronic acid nano microgel loaded with anti-cancer medicine and preparation method for hyaluronic acid nano microgel |
| 01/16/2013 | CN102871950A 一种熊果酸固体分散体及其制备方法 One kind of ursolic acid solid dispersion and its preparation method |
| 01/16/2013 | CN102397245B Nicardipine hydrochloride glucose injection |
| 01/16/2013 | CN102379853B Vidarabine monophosphate freeze-dried powder injection and preparation method thereof |
| 01/16/2013 | CN102362855B Itraconazole isomer oral liquid |
| 01/16/2013 | CN102357072B Injection preparation of T-2 lienomycin |
| 01/16/2013 | CN102335119B New preparation for chemotherapy on tumor vascular thrombosis mediated by biological effect of ultrasound |
| 01/16/2013 | CN102295772B Monomethoxy polyethylene glycol-poly(L-tryptophan) amphipathic segmented copolymer, preparation method thereof and preparation method of drug loaded miceller solution thereof |
| 01/16/2013 | CN102276813B Targeting polymer drug carrier containing folic acid and preparation method thereof |
| 01/16/2013 | CN102274197B Ganciclovir composition for injection and preparation method thereof |
| 01/16/2013 | CN102266291B Preparation method of strychnine immune nanoparticles |
| 01/16/2013 | CN102251317B Preparation method of electrospun fibers with controllable drug release |
| 01/16/2013 | CN102239961B Flavoring agent |
| 01/16/2013 | CN102228693B Preparation method for drug release hydrogel membrane with electron beam |
| 01/16/2013 | CN102228469B Nano-selenium particles and preparation method thereof |
| 01/16/2013 | CN102228425B Tumor-targeted magnetic hydrogel nanoscale medicine delivery system and construction method and application thereof |
| 01/16/2013 | CN102225054B Preparation carried with particles of antitumor drug and preparation method thereof |
| 01/16/2013 | CN102210867B pH reversible response mesoporous silicon oxide composite medicament-carrying system, preparation method thereof and application thereof |
| 01/16/2013 | CN102151285B Neutral calcium supplement preparation |
| 01/16/2013 | CN102144987B Metoprolol oral pulsatile tablet and preparation method and application of metoprolol oral pulsatile tablet |
| 01/16/2013 | CN102133404B Tumor targeted therapeutic drug carrier as well as preparation method and application thereof |
| 01/16/2013 | CN102125522B P-glycoprotein monoclonal antibody modified phenytoin targeting nanopreparation and preparation method thereof |
| 01/16/2013 | CN101948543B Fusion protein and coding gene and application thereof |
| 01/16/2013 | CN101904893B Angelica sinensis blood enriching capsule and preparation method thereof |
| 01/16/2013 | CN101869633B Enteric-coated medicament combination containing epigallocatechin gallate |
| 01/16/2013 | CN101815510B Pharmaceutical preparations containing highly volatile silicones |
| 01/16/2013 | CN101773481B Chewable tablet containing montelukast sodium |
| 01/16/2013 | CN101636182B Novel psychotropic agents having glutamate NMDA activity |
| 01/16/2013 | CN101632627B Solution for ungual and peri-ungual application |
| 01/16/2013 | CN101627057B Polyrotaxanes and material having polyrotaxane, crosslinked polyrotaxanes and material having the crosslinked polyrotaxane, and processes for producing these |
| 01/16/2013 | CN101497671B 羟烷基淀粉衍生物 Hydroxyalkyl starch derivative |
| 01/16/2013 | CN101411876B Neurotoxic oligomers |
| 01/16/2013 | CN101405032B Anti-infective solution comprising a compound of pyrido(3,2,1-ij)-benzoxadiazine type |
| 01/16/2013 | CN101352449B 维生素口腔崩解片及其制备方法 Vitamin orally disintegrating tablets and preparation method |
| 01/16/2013 | CN101325944B Compositions for nasal delivery |
| 01/16/2013 | CN101322683B Gel for eye containing bromfenac sodium hydrate and preparation thereof |
| 01/16/2013 | CN101277674B Stabilization of body-care and household products against degradation by UV radiation using merocyanine derivatives |
| 01/15/2013 | US8354477 Multi-armed, monofunctional, and hydrolytically stable derivatives of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
| 01/15/2013 | US8354409 Combination of brimonidine and timolol for topical ophthalmic use |
| 01/15/2013 | US8354387 Methods and compositions for delivering siRNA into mammalian cells |
| 01/15/2013 | US8354376 Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects |
| 01/15/2013 | US8354124 Oral drug delivery system |
| 01/15/2013 | CA2712821C Use of oxidase inhibitor with dextromethorphan to treat intractable coughing and dermatitis |
| 01/15/2013 | CA2637564C Thimerosal removal device |
| 01/15/2013 | CA2574664C Compound formulations of 2-amino-1,3-propanediol compounds |
| 01/15/2013 | CA2573042C Process for the preparation and use of a bivalent vaccine against morphine-heroin addiction |
| 01/15/2013 | CA2558254C Cream-gel containing ivermectin |
| 01/15/2013 | CA2424607C Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 01/13/2013 | CA2783115A1 Jelly-form preparation and method for producing jelly-form preparation |
| 01/10/2013 | WO2013006837A1 Cationic oil-in-water emulsions |
| 01/10/2013 | WO2013006763A1 Oral delivery of enzymes by nanocapsules for targeted metabolism of alcohol or toxic metabolites |
| 01/10/2013 | WO2013006706A1 P97-antibody conjugates and methods of use |
| 01/10/2013 | WO2013006454A1 Arginine - free tnfr : fc- fusion polypeptide compositions and methods of use |
| 01/10/2013 | WO2013006333A1 Pulmonary delivery of 17-hydroxyprogesterone caproate (17-hpc) |
| 01/10/2013 | WO2013006173A1 Fluorinated block co-polymers |
| 01/10/2013 | WO2013006163A1 Oral rehydration composition |
| 01/10/2013 | WO2013005760A1 Adhesive skin patch containing serotonin receptor antagonist drug |
| 01/10/2013 | WO2013005226A1 A novel combined pharmaceutical composition containing diclofenac and methods of making and using the same |
| 01/10/2013 | WO2013004830A1 Pharmaceutical composition and solid galenic form having a high dronedarone content, and method for preparing same |
| 01/10/2013 | WO2013004716A1 Peptide beads |
| 01/10/2013 | WO2013004462A1 A complex of amorphous tomoxiprole and cyclodextrin with fast dissolution rate and process for the preparation thereof |
| 01/10/2013 | WO2013004249A1 The use of serotonin receptor agonists for treatment of movement disorders |
| 01/10/2013 | WO2013003987A1 Tumor-targeted tumor necrosis factor-related apoptosis ligand variant and use thereof |
| 01/10/2013 | WO2013003947A1 Iron supplement composition |
| 01/10/2013 | WO2013003887A1 Nucleic acid complex |
| 01/10/2013 | WO2012158965A3 Improved peptide pharmaceuticals for insulin resistance |
| 01/10/2013 | WO2012158493A3 Compounds that bind to the erythropoietin receptor |
| 01/10/2013 | WO2012156999A4 Ready to use docetaxel formulation |
| 01/10/2013 | WO2012149160A3 Viruses modified with unnatural moieties and methods of use thereof |
| 01/10/2013 | WO2012144789A3 Non-animal soft capsule shell composition having improved disintegration and shell hardness |
| 01/10/2013 | WO2012140680A8 Nanotori of semiconductor material for use in diagnostics and in the anti-tumor therapy and process for the production thereof |
| 01/10/2013 | WO2012121988A3 Methods for treating diseases using isoindoline compounds |
| 01/10/2013 | WO2012117115A3 Use of a viscoelastic fluid for producing a medicinal product for surgically treating the eye |
| 01/10/2013 | WO2012097223A3 Oligosaccharide conjugates for targeting bacteria and uses related thereto |
| 01/10/2013 | WO2012071441A3 Biodegradable stealth polymeric particles fabricated using the macromonomer approach by free radical dispersion polymerization |
| 01/10/2013 | WO2012018115A9 Composition for regenerating normal tissue from fibrotic tissue |
| 01/10/2013 | WO2011131370A8 Melt-granulated fingolimod |
| 01/10/2013 | WO2011130834A8 Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof |
| 01/10/2013 | US20130012754 Microwave induced photodynamic therapy |
| 01/10/2013 | US20130012601 Fluid Cocamide Monoethanolamide Concentrates And Methods Of Preparation |
| 01/10/2013 | US20130012600 Method of treating animal's exterior for cleaning and/or insect repellency |
| 01/10/2013 | US20130012599 Surface treatment for gasified consumable materials |
| 01/10/2013 | US20130012598 Apparatus and methods for fabricating nanofibers from sheared solutions under continuous flow |
| 01/10/2013 | US20130012597 Temperature-, ph- or salt concentration-sensitive separation material and use thereof |
| 01/10/2013 | US20130012596 Polymerization of alkyl(beta-n-alkylaminopropionates) forming unique polyamide compositions |
| 01/10/2013 | US20130012567 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/10/2013 | US20130012542 Injectable depot formulation comprising crystals of iloperidone |
| 01/10/2013 | US20130012535 Sustained-release solid preparation for oral use |
| 01/10/2013 | US20130012474 Cellulose Gel Formulations |
| 01/10/2013 | US20130011490 High alcohol content foaming compositions with silicone-based surfactants |
| 01/10/2013 | US20130011467 Method of treating malignant solid tumors using transcatheter arterial chemoembolization (tace) |
| 01/10/2013 | US20130011464 Drug carrier and drug carrier kit for inhibiting fibrosis |